Rare diseases
Investigational molecules
Locations
Suite 1 Level 3, 62 Lygon Street, 3053
Clinical research in advanced solid tumours, with interest in treatment settings where disease control remains limited and new systemic options are needed.
The sponsor’s active research focus includes clinical development in tumour-directed therapy and combination approaches involving immune checkpoint inhibitor treatment.
Domain Therapeutics Australia Pty Limited runs clinical trials in conditions such as Neoplasm malignant, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
